Genome Biologics
PrivateLast Round
VC Round
Dec 20, 2021
Total Funding Raised
$3.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genome Biologics is a biotechnology company that provides human cardiac organoid services for drug discovery, cardiac safety pharmacology, and disease modeling.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genome Biologics Comparables
Compare Genome Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HeartBeat.bio AG | 90% | |
| Ncardia | 83% | |
| Dynomics | 82% |
Genome Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 20, 2021 | ||||
| Grant | Sep 1, 2018 |
Genome Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Innovation Council Fund | VC Round |
| Johnson & Johnson Innovation - JLABS | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 39% MoM.
- Jan 20, 2026
Monthly visitors increased 1527% MoM.
Genome Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genome Biologics's valuation, stock price, and market status.
Is Genome Biologics a public or private company?
Genome Biologics is a private company.
What is the current stock price of Genome Biologics?
Genome Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Genome Biologics worth (valuation)?
Valuation information for Genome Biologics is not publicly available.
Can I buy Genome Biologics stock?
Genome Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genome Biologics's last funding round?
Genome Biologics's most recent funding round was VC Round on December 20, 2021.
Who are the main investors in Genome Biologics?
Key investors in Genome Biologics include Horizon 2020, European Innovation Council, Johnson & Johnson Innovation - JLABS.
Will Genome Biologics IPO soon?
No public IPO plans have been announced for Genome Biologics.
How can I track Genome Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genome Biologics's secondary market activity and sign up for updates.